A prescription can change one person’s appetite. The household still needs a plan for dinner.
The headline usually tells you how much weight people lost. Before you commit, ask what it costs to keep going, how side effects will be handled, what happens if you stop and who will help you build habits you can use at home.
GLP-1 medicines such as semaglutide and dual GIP/GLP-1 medicines such as tirzepatide can offer meaningful benefits. They can also turn into a long-term treatment commitment. A responsible offer should explain that commitment before the first payment.
My concern is with sales pitches that give the weight-loss number centre stage and leave the ongoing cost, support and maintenance plan to the fine print. Those details can determine whether a treatment is workable for a family.
Long-term use can be viable for some people. WHO conditionally supports it for adults living with obesity, while identifying gaps in long-term safety, maintenance and discontinuation evidence, along with high costs and uneven access. Several years of follow-up cannot answer every question about decades of treatment.
In SELECT, adults with established cardiovascular disease and overweight or obesity, without diabetes, had a major cardiovascular event rate of 6.5% on semaglutide versus 8.0% on placebo over roughly 40 months of average follow-up. A separate analysis found that weight loss persisted for up to four years during treatment. These results concern a specific high-risk population.
|
After treatment changes |
What researchers observed |
|
Semaglutide • STEP 1 extension |
A subset regained about two-thirds of prior weight loss on average within one year of stopping medication and the trial’s lifestyle intervention. |
|
Tirzepatide • SURMOUNT-4 |
After a 36-week lead-in, participants switched to placebo gained 14.0% from their weight at randomisation over the next 52 weeks. Those who continued lost a further 5.5%. Both groups received lifestyle counselling. |
These are group averages. People vary, and the studies used different designs. Neither trial establishes that everyone will regain all their weight or that a particular coaching program will prevent regain. Returning hunger and weight regain deserve clinical support, free of blame.
|
Retail example |
Four weeks |
52 weeks at same price |
|
Wegovy 2.4 mg pen |
A$369.99 |
A$4,809.87 |
|
Mounjaro 15 mg pen |
A$689.99 |
A$8,969.87 |
Illustrative Australian private retail prices for four-dose pens, multiplied by 13. These are selected doses, not starting prices or treatment recommendations. Consultations, coaching and other fees are excluded. Ask for a written estimate at your likely dose and check whether any subsidy applies to your indication.
Nausea, vomiting, diarrhoea and constipation are recognised side effects. Severe or persistent symptoms deserve prompt review, especially if someone cannot keep fluids down. Product information also warns about gallbladder problems and pancreatitis. Tell the anaesthetic team about the medicine ahead of a procedure because delayed stomach emptying can affect care.
The Australian TGA has updated warnings for a rare but serious optic nerve condition called NAION. Sudden vision loss or a rapid deterioration in vision needs urgent medical assessment. Ask your pharmacist or prescriber which warnings apply to your specific medicine and what to do if symptoms occur.
Picture the person who usually shops and cooks. If a smaller appetite or nausea makes dinner unappealing, who takes over the shopping list, cooking and clean-up? Does the family eat together less often? Do takeaway costs rise? These are practical questions to discuss, rather than outcomes we can assume for every household.
Agree on a few shared meals, divide shopping and cooking among household members and keep simple backup meals available. Let people serve portions that suit their own needs. Children need food appropriate for growth and should be kept out of adult weight-loss targets and restrictive meal rules.
Medication can ease appetite pressures for some people. Education can help the household turn that space into usable skills, from planning groceries and preparing affordable meals to agreeing on routines for busy weeks. WHO recommends context-appropriate counselling on dietary practices and physical activity as part of care. [1]
Ask the pharmacy or clinic who teaches food skills, who checks tolerability and when the next appointment is booked. If you need individual nutrition care, ask about an accredited practising dietitian. If cost, availability or side effects force a change, contact the prescriber to agree on a plan for treatment, appetite changes and follow-up. Evidence for a reliable taper that prevents regain remains limited.
What is realistic for someone with my health profile, and when will we review progress?
What do medication, consultations and education cost over a year at the expected dose?
Who teaches practical skills and helps me keep them going at home?
Who follows up if I continue, switch or need to stop?
At WeightLossForLife, I want pharmacies to make practical food education and maintenance planning visible from the start. A clearly priced professional service could give patients dedicated time and structured resources, with clinical decisions staying with the prescriber. Pharmacy owners interested in testing that model are invited to contact WeightLossForLife.
2. SELECT cardiovascular outcomes
3. SELECT four-year weight analysis
4. STEP 1 withdrawal extension
5. SURMOUNT-4 withdrawal trial
6. TGA Wegovy and product information
7. TGA class safety information
9. Chemist Warehouse Wegovy price
10. Chemist Warehouse Mounjaro price